Events

A new targeted oral therapy is changing the landscape for people with hormone receptor positive, HER2 negative metastatic breast cancer, offering another option for those whose disease has progressed on prior treatment. This practical session will step through how the treatment works, when it is used and what makes its side effect profile distinct.

Cancer can impact intimacy, body confidence and sexual wellbeing. This webinar explores sexual wellbeing after cancer for women and men, with practical strategies to support reconnection, confidence and intimacy after treatment.

Join our CNSA WA State Group for breakfast on Saturday 21 February to hear what's happening now and in the future for Gynaecological Cancers. Our expert speakers will cover evidence-informed strategies to support patients across diagnosis, treatment and survivorship.

The McGrath Model of Care is a framework for the delivery of cancer care nursing. In this webinar, we'll unpack the newly developed Model of Care that reflects the delivery of high-quality supportive care cancer nursing for any type of cancer.

Launch 2026 with a new beginning - The NSW Hunter State Group invites you to join us for an inspirational session providing communication strategies and clinical knowledge to better support patients navigating the deeply personal issues of pregnancy and fertility throughout treatment and survivorship.

Restore vitality, strengthen connections, reduce burnout and improve mindfulness and functioning. With only 20 spots available, get in early to secure your relaxing TREAT!

Join us for our first flagship event of the year - an expert-led session exploring how endocrine therapy is used in breast cancer and how to protect intimacy and sexual wellbeing during treatment.

This event offers practical guidance on recognising end-of-life needs, managing symptoms, and navigating sensitive conversations. Ideal for nurses and health professionals looking to strengthen their care approach at one of the most important stages of the cancer journey.